The success rate of CT-guided bone biopsies for molecular analyses in metastatic PCa patients is approximately only 40%, whereas they found that the success rate of 68Ga-PSMA-guided (i.e. PET/CT-guided) biopsies for molecular analyses was 70%. Here, FOLH1 is linked to posterior cortical atrophy.